Stock Ticker

  • Loading stock data...

OncBioMune Shows Compelling Results Compared to Paclitaxel in Ovarian Cancer Experiment

Despite a plethora of advancements in cancer care in recent decades, ovarian cancer remains a great challenge.  In 2019, an estimated 22,530 women will be diagnosed with the ovarian cancer, while the disease will take the lives of about 13,980 women, making it the fifth most lethal form of cancer in the U.S. It was […]

Sign Up To Get Our Latest Stocks Alerts